Biopôle Clermont-Limagne
Technology park for life sciences


Industries and networks

  • Capture.JPG




Life science technologies account for a sizeable portion of the Puy-de-Dôme’s industrial fabric.


With sales of 3.25 billion euros and manpower of close to 11,500 in 322 businesses, the food activity is the third-biggest sector of Auvergne. The pharmaceutical industry is also strongly anchored in Auvergne by way of numerous major groups as well as a network of SMEs.


Thirty or so businesses employ close to 3,000 people, over 75% of which based in Puy de Dôme. There are approximately fifty businesses operating in the biotechnology sector. The majority are set up on the Biopole Clermont-Limagne.


Avergne’s highly responsive industrial environment is rooted in a structure of varied networks giving rise to dynamic federating business pools and competitiveness clusters.

  • Auvergne excellence cluster
  • Competitiveness cluster
  • Business cluster
  • Cancer consortium
  • Business group
  • Institute


  • Technology platforms
  • Call for projects / Research programs

The Cancéropôle Lyon Auvergne Rhône-Alpes (CLARA) is one of seven canceropôles created in 2003 under the national Cancer Plan.

It is structured into platforms headed by major figures in cancer research in Auvergne and Rhône-Alpes focusing on 6 fields of research:

• Tumour Escape, Cell Plasticity and Targeted Therapies

• Infections and Cancer

• Nanotechnology, Imaging and Cancer

• Evaluation, Perception of Risks and Prevention of Cancer

• Environment, Nutrition and Cancer

• Hadron therapy and Cancer

The Clermont Ferrand hub pools skills in high speed genotyping, metabolomics and functional imaging by radiotracers.

Chemistry - Environment
  • Identifying new avenues of business
  • Establishment of collaborative projects

Eco Entreprises pour l’Innovation en Auvergne (Eco businesses for innovation in Auvergne) rounds up all the regional eco-business stakeholders (SMEs, SMIs, research laboratories, institutional heads) in order to stimulate mutual business, create additional expertise, respond to joint projects and promote the sector.

The association supports the pooling of skills both in terms of R & D as well as economic activity. Its spheres of expertise range from prevention, diagnostics, including implementation and the proposal of bespoke solutions.


  • Facilitation of exchanges and partnerships between memebers
  • Promotion of the sector to institutions and public authorities

Le Groupement des Industries du Médicament en Région Auvergne (Auvergne regional pharmaceutical industry group) brings together industrial, academic and institutional partners of the pharmaceutical sector of Auvergne.

It promotes exchanges and collaborative partnerships between its members, is proactive in bolstering their business and skills, while developing cooperations with other healthcare professionals, the universities and other educational and research structures.

See sheet



Thermalism and health
  • Establishment of collaborative projects 
  • Development of products, care programs or health prevention programs scientifically validated 

Made up of fifteen or so members, the Innovatherm cluster develops collaborative and innovative partnerships in the spa industry. 

Food, nutrition, probiotics, food supplements, cosmetology, well-being tourism or renewable energies such as geothermal energy are all fields which the cluster intends to explore with a view to further developments.
Its initiatives are geared towards global health and its intention is to broaden its thermal therapy scope, including care and support to the elderly, management of diseases of society, overall patient care and subsequent care.


Pain treatment
  • Preclinical and clinical R&D plateform
  • Establishment of collaborative projects 
  • Foundation

The Analgesia Institute is the first centre in France dedicated to research and innovation against pain. It is set up in Auvergne with a firm commitment to excellence via a network structure in French which is poised to go international. 

It brings together clinicians, researchers and businesses with one and the same ambition in mind:  to make breakthroughs against pain by developing innovative, safe, efficient and ever-personalised analgesics. 


  • R&D plateform
  • Establishment of collaborative projects
  • Campaining for official medical product status for probiotic products

L’Institut de Recherche Probiotique (Probiotics research institute) is made up of SMEs, public and private-sector research laboratories and training centres.

It is tasked with meeting the requirements of the pharmaceutical industry in probiotic R & D with two focuses in mind:
• obtaining drug regulatory status pertaining to probiotics, enabling treatment indications to be claimed,
• federating an expertise hub in order to host and handle R & D projects upstream (screening of new strains) and downstream (production of a finished product complying with the GMP regulations).


Innovation in the plant field
  • R&D projects
  • Industrial projects
  • International support

Végépolys Valley is a competitiveness cluster gathering together 500 members, firms, research and training centres in the plant field around some innovative projects to strengthen the firms’ competitiveness.


See sheet

Biotechnology - Health
  • R&D projects
  • Industrial projects
  • International support

As a Cluster, Lyonbiopole is the gateway to healthcare innovation in the Auvergne-Rhône-Alpes region. It’s supporting ambitious projects and innovative companies in the healthcare & life sciences’ sector. Its aim is to help innovators develop new technologies, products and services in a push toward a more personalized medicine and better treatments for patients.

Its 4 strategic areas:

- human medicine         

- Veterinary medicine

- In vitro diagnostics

- medical devices and medical technologies